Brief: Palvella Therapeutics Announces Pricing Of Upsized Public Offering
26/02/2026 24:59
Feb 25 (Reuters) - Palvella Therapeutics Inc PVLA.O: PALVELLA THERAPEUTICS ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING PALVELLA THERAPEUTICS INC - EXPECTS $200 MILLION GROSS PROCEEDS FROM OFFERING PALVELLA THERAPEUTICS INC: PRICES ITS UPSIZED PUBLIC OFFERING OF 1.6 MILLION SHARES AT $125.00 PER SHARE Source text: ID:nGNXjljfF Further company coverage: PVLA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palvella Therapeutics
See all newsPalvella Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Palvella Therapeutics Q2 net loss widens on higher expenses
Brief: Palvella Therapeutics Announces New Data From The Phase 2 Toiva Trial Of Qtorin™ Rapamycin In Cutaneous Venous Malformations
Brief: Palvella Therapeutics Announces Uplisting To The Nasdaq Global Market
Palvella Therapeutics' Q1 net loss widens on higher costs